speb/financial-data huggingface dataset:
Financial ratios for DELIA.OL — annual report dated 2025-12-31
Total revenue: 63511542.28855721
Gross profit: 20937611.940298505
Operating income: 7409054.726368159
Net income: 4894427.860696517
Capital expenditures: 462189.0547263681
Operating cash flow: -3107263.6815920398
Depreciation & amortization: 259800.9950248756
Net tangible assets: 38522686.567164175
Owner earnings: 4692039.800995025
Return on net tangible assets (%): 12.179939197164947
Capex to operating income (%): 6.238164945407663
Buffett classification: The Great
Stock price: 4.0398406374502
P/E ratio: 35.54554191601321
Shares outstanding: 43064840
Book value: 38522686.567164175
P/B ratio: 4.516172317680022
Market cap (USD): 173975090.6772909
Debt to equity: 0.3034330096886761
Current ratio: 2.89628539353873
Quick ratio: 1.940870649869028
Effective tax rate (%): 23.25095175684953
Interest coverage ratio: 24.27812194326704
COGS to revenue (%): 67.03337505933814
R&D to revenue (%): 0.45997828576621014
SG&A to revenue (%): 14.399701703455008
Free cash flow (dilution-adjusted): -3569452.7363184076
Buyback yield (%): 0
Retained earnings: 1291343.2835820895
Inventory turnover: 2.234425998360219
Receivables turnover: 8.448590337524818
Capitalized R&D asset: 657530.638100246
ROCI (R&D-adjusted, %): 18.47622985012527
Rosenberg metric: 24.60663213604834
FCF margin (%): -5.620163843764051
Revenue growth (%): 170.54842940048547
Rule of 40 score: 164.9282655567214
Financial ratios for DELIA.OL — quarterly report dated 2025-12-31
Total revenue: 15202487.562189054
Gross profit: 4751144.278606965
Operating income: 911741.2935323382
Net income: 671940.2985074626
Capital expenditures: 43781.09452736318
Operating cash flow: -3799104.47761194
Depreciation & amortization: 84179.10447761194
Net tangible assets: 38522686.567164175
Owner earnings: 712338.3084577114
Return on net tangible assets (%): 1.8491397457852579
Capex to operating income (%): 4.8019207683073235
Buffett classification: The Great
Stock price: 4.0398406374502
P/E ratio: 35.76333681694682
Shares outstanding: 43064840
Book value: 38522686.567164175
P/B ratio: 4.516172317680022
Market cap (USD): 173975090.6772909
Debt to equity: 0.3034330096886761
Current ratio: 2.89628539353873
Quick ratio: 1.940870649869028
Effective tax rate (%): 12.321474941573618
Interest coverage ratio: 1.7278898736564208
COGS to revenue (%): 68.74758647773015
Free cash flow (dilution-adjusted): -3842885.572139303
Buyback yield (%): 0
Retained earnings: 1291343.2835820895
Inventory turnover: 0.5485223694311423
Receivables turnover: 2.0223031105228326
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.308356992963832
FCF margin (%): -25.27800503976176
Revenue growth (%): -26.143318824955575
Rule of 40 score: -51.42132386471734
Financial ratios for DIXON.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 56.71159171831729
Shares outstanding: 60801893
Market cap (USD): 3448172131.5168138
Buyback yield (%): 0
Retained earnings: 94665699.59119083
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIXON.NS — annual report dated 2023-03-31
Total revenue: 1482746650.4263096
Gross profit: 136997563.94640684
Operating income: 49606577.34470159
Net income: 31123020.706455544
Capital expenditures: 1337393.4226552986
Operating cash flow: 88398294.76248477
Depreciation & amortization: 13962241.169305725
Net tangible assets: 150080389.76857492
Owner earnings: 43747868.45310597
Return on net tangible assets (%): 29.149623425529153
Capex to operating income (%): 2.696000196429887
Buffett classification: The Great
Stock price: 34.801948842874545
P/E ratio: 67.98904224926424
Shares outstanding: 60801893
Book value: 156471376.37028015
P/B ratio: 13.523395900400894
Market cap (USD): 2116024369.7359319
Debt to equity: 0.35270077765582314
Current ratio: 1.0674194743946765
Quick ratio: 0.7417230252398002
Effective tax rate (%): 26.016590289459945
Interest coverage ratio: 7.228789492367768
COGS to revenue (%): 90.7605548185175
SG&A to revenue (%): 0.33047599880065875
Free cash flow (dilution-adjusted): 30783191.230207067
Buyback yield (%): 0
Retained earnings: 117110840.43848966
Inventory turnover: 11.534550617515949
Receivables turnover: 7.0963012620595185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.42732564828237
FCF margin (%): 2.0760924478471416
Rule of 40 score: 2.0760924478471416
Financial ratios for DIXON.NS — annual report dated 2024-03-31
Total revenue: 2112232881.6404846
Gross profit: 182434344.64564097
Operating income: 65012591.43782228
Net income: 44959827.31742415
Capital expenditures: 1901906.7034416597
Operating cash flow: 70069552.70416117
Depreciation & amortization: 19412399.56829356
Net tangible assets: 195445497.06199783
Owner earnings: 62470320.18227605
Return on net tangible assets (%): 31.963038863187343
Capex to operating income (%): 2.9254436123510534
Buffett classification: The Great
Stock price: 89.65031190019194
P/E ratio: 121.23953753397983
Shares outstanding: 60801893
Book value: 206554742.77491295
P/B ratio: 26.389656312622492
Market cap (USD): 5450908671.572097
Debt to equity: 0.2838846765672354
Current ratio: 1.0221192741598015
Quick ratio: 0.6638889006302282
Effective tax rate (%): 24.079136544964864
Interest coverage ratio: 7.5972533632287
COGS to revenue (%): 91.36296256765249
SG&A to revenue (%): 0.2645068584999015
Free cash flow (dilution-adjusted): -1478594.5557021224
Buyback yield (%): 0
Retained earnings: 157256265.73929727
Inventory turnover: 9.494097379956461
Receivables turnover: 7.599146633993132
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.99030015532142
FCF margin (%): -0.07000149313809369
Revenue growth (%): 42.45406530058181
Rule of 40 score: 42.38406380744372
Financial ratios for DIXON.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 254841137.12374583
Buffett classification: The Gruesome
Stock price: 164.79706163401815
Shares outstanding: 60801893
Book value: 307612279.02532244
P/B ratio: 32.5733853665872
Market cap (USD): 10019973308.185976
Debt to equity: 0.3083022369948706
Current ratio: 1.0334770329476413
Quick ratio: 0.7381403901847761
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIXON.NS — quarterly report dated 2024-12-31
Total revenue: 1218519640.9837976
Gross profit: 90170183.00501223
Operating income: 36824804.75579904
Net income: 25204569.297120873
Capital expenditures: 0
Depreciation & amortization: 8695652.173913043
Owner earnings: 33900221.471033916
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 208.97913509733067
P/E ratio: 126.03197917839339
Shares outstanding: 60801893
Market cap (USD): 12706327011.420444
Effective tax rate (%): 24.164416231192792
Interest coverage ratio: 7.729875214093467
COGS to revenue (%): 92.60002219314156
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIXON.NS — quarterly report dated 2025-03-31
Total revenue: 1203242927.2854805
Gross profit: 95538929.15595043
Operating income: 41720832.359130226
Net income: 54354687.86532616
Capital expenditures: 0
Depreciation & amortization: 10043254.617722701
Net tangible assets: 340641805.0035071
Owner earnings: 64397942.483048856
Return on net tangible assets (%): 18.90488528922216
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 153.73602520714203
P/E ratio: 42.992802102230705
Shares outstanding: 60801893
Book value: 405579845.6862285
P/B ratio: 23.04710516143713
Market cap (USD): 9347441354.889954
Debt to equity: 0.1933975724419413
Current ratio: 1.0396127487408142
Quick ratio: 0.7226408922594207
Effective tax rate (%): 19.283717861916912
Interest coverage ratio: 7.714656290531776
COGS to revenue (%): 92.05988026279228
Buyback yield (%): 0
Retained earnings: 277529810.614917
Inventory turnover: 2.37333433523695
Receivables turnover: 1.4776561456905155
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.555339535842624
Revenue growth (%): -1.253710911543705
Rule of 40 score: -1.253710911543705
Financial ratios for DIXON.NS — annual report dated 2025-03-31
Total revenue: 4542915595.043254
Gross profit: 353902267.9448211
Operating income: 143390226.7944821
Net income: 144093991.1152677
Capital expenditures: 5115735.328501286
Operating cash flow: 134410801.96399343
Depreciation & amortization: 32852466.682253912
Net tangible assets: 340641805.0035071
Owner earnings: 171830722.4690203
Return on net tangible assets (%): 50.443228031641986
Capex to operating income (%): 3.5677015392642843
Buffett classification: The Great
Stock price: 153.73602520714203
P/E ratio: 64.87044520414794
Shares outstanding: 60801893
Book value: 405579845.6862285
P/B ratio: 23.04710516143713
Market cap (USD): 9347441354.889954
Debt to equity: 0.1933975724419413
Current ratio: 1.0396127487408142
Quick ratio: 0.7226408922594207
Effective tax rate (%): 21.481717416231362
Interest coverage ratio: 7.946614836410755
COGS to revenue (%): 92.20979873958122
SG&A to revenue (%): 0.14655134701145908
Free cash flow (dilution-adjusted): 14645779.75216273
Buyback yield (%): 0
Retained earnings: 277529810.614917
Inventory turnover: 8.975257990181344
Receivables turnover: 5.578979104006201
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.403825546635087
FCF margin (%): 0.32238723008947484
Revenue growth (%): 115.0764546149361
Rule of 40 score: 115.39884184502557
Financial ratios for DIXON.NS — quarterly report dated 2025-06-30
Total revenue: 1501949450.0351043
Gross profit: 112410484.43716359
Operating income: 45596770.41890944
Net income: 32766206.41235666
Capital expenditures: 0
Depreciation & amortization: 10847179.967236135
Owner earnings: 43613386.37959279
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 175.24373976129183
P/E ratio: 94.85962287429209
Shares outstanding: 60801893
Market cap (USD): 10655151113.885912
Effective tax rate (%): 23.391332895600787
Interest coverage ratio: 11.956735194845045
COGS to revenue (%): 92.51569455719456
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 24.825121841647267
Rule of 40 score: 24.825121841647267
Financial ratios for DIXON.NS — quarterly report dated 2025-12-31
Total revenue: 1188770190.4867997
Gross profit: 87537039.09992203
Operating income: 35136459.84181798
Net income: 35709034.1985073
Capital expenditures: 17942519.77275259
Operating cash flow: 23188147.488024954
Depreciation & amortization: 11031525.008354684
Owner earnings: 28798039.434109397
Capex to operating income (%): 51.06524633821571
Buffett classification: The Good
Stock price: 134.81118413723962
P/E ratio: 55.37070964139502
Shares outstanding: 60801893
Market cap (USD): 8196775193.115741
Effective tax rate (%): 22.135587456581405
Interest coverage ratio: 7.357592722183345
COGS to revenue (%): 92.63633629103066
Free cash flow (dilution-adjusted): 5245627.715272363
Buyback yield (%): 0
Capitalized R&D asset: 0
FCF margin (%): 0.4412650785871646
Revenue growth (%): -20.851517974921514
Rule of 40 score: -20.41025289633435
Financial ratios for DRDB — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -341380
Net income: 2214005
Capital expenditures: 0
Operating cash flow: -323430
Net tangible assets: 234887039
Owner earnings: 2214005
Return on net tangible assets (%): 0.9425828727825208
Buffett classification: The Gruesome
Stock price: 10.03
P/E ratio: 26.048947495601862
Shares outstanding: 23000000
Book value: 234887039
P/B ratio: 0.9821316705346181
Market cap (USD): 230690000
Debt to equity: 0
Current ratio: 15.14205749470233
Quick ratio: 15.14205749470233
Free cash flow (dilution-adjusted): -323430
Buyback yield (%): 0
Retained earnings: 1132396
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.14533794689284665
Rule of 40 score: 0
Financial ratios for DRDB — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -513304
Net income: 2137767
Capital expenditures: 0
Operating cash flow: -295138
Net tangible assets: 239052676
Owner earnings: 2137767
Return on net tangible assets (%): 0.8942660821751269
Buffett classification: The Gruesome
Stock price: 10.32
P/E ratio: 27.757936201653408
Shares outstanding: 23000000
Book value: 239052676
P/B ratio: 0.9929192342527887
Market cap (USD): 237360000
Debt to equity: 0
Current ratio: 1.746050062778056
Quick ratio: 1.746050062778056
Free cash flow (dilution-adjusted): -295138
Buyback yield (%): 0
Retained earnings: 224367
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.21472422253913612
Rule of 40 score: 0
Financial ratios for DRDB — annual report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 240410462
Buffett classification: The Gruesome
Stock price: 10.43
Shares outstanding: 23000000
Book value: 240410462
P/B ratio: 0.9978351108530377
Market cap (USD): 239890000
Debt to equity: 0.0008319105513802474
Current ratio: 0.35466647317217476
Quick ratio: 0.35466647317217476
Buyback yield (%): 0
Retained earnings: -778860
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DRDB — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 240410462
Buffett classification: The Gruesome
Stock price: 10.43
Shares outstanding: 23000000
Book value: 240410462
P/B ratio: 0.9978351108530377
Market cap (USD): 239890000
Debt to equity: 0.0008319105513802474
Current ratio: 0.35466647317217476
Quick ratio: 0.35466647317217476
Buyback yield (%): 0
Retained earnings: -778860
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DUL.DE — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 89694000
Buffett classification: The Gruesome
Stock price: 170.79545454545456
Shares outstanding: 133512573
Market cap (USD): 22803340593.068184
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DUL.DE — annual report dated 2022-12-31
Total revenue: 1037418000
Gross profit: 868601000
Operating income: -785072000
Net income: -1131156000
Capital expenditures: 72059000
Operating cash flow: -541274000
Depreciation & amortization: 85550000
Net tangible assets: -158223000
Owner earnings: -1117665000
Buffett classification: The Gruesome
Stock price: 241.70212765957447
Shares outstanding: 133512573
Book value: -158223000
Market cap (USD): 32270272963.404255
Debt to equity: -8.344223026993546
Current ratio: 3.50591797269229
Quick ratio: 3.3379801149866846
Interest coverage ratio: -5.033545342634387
COGS to revenue (%): 16.27280421199555
R&D to revenue (%): 85.11660680651386
SG&A to revenue (%): 74.28616044834388
Free cash flow (dilution-adjusted): -843982000
Buyback yield (%): 0
Retained earnings: -6569349000
Inventory turnover: 1.309044524743723
Receivables turnover: 4.359576909015267
Capitalized R&D asset: 883015000
ROCI (R&D-adjusted, %): -5.363854499895624
FCF margin (%): -81.35409256442438
Rule of 40 score: -81.35409256442438
Financial ratios for DUL.DE — annual report dated 2023-12-31
Total revenue: 1828292000
Gross profit: 1517886000
Operating income: -282175000
Net income: -440242000
Capital expenditures: 62211000
Operating cash flow: 104156000
Depreciation & amortization: 97031000
Net tangible assets: -220644000
Owner earnings: -405422000
Buffett classification: The Gruesome
Stock price: 252.44444444444443
Shares outstanding: 133512573
Book value: -220644000
Market cap (USD): 33704507317.333332
Debt to equity: -5.916258769782999
Current ratio: 3.0819799005151967
Quick ratio: 2.989866561409237
Interest coverage ratio: -2.3277732406101252
COGS to revenue (%): 16.97792256379178
R&D to revenue (%): 54.93734042483367
SG&A to revenue (%): 43.51854080201631
Free cash flow (dilution-adjusted): -179735000
Buyback yield (%): 0
Retained earnings: -7009591000
Inventory turnover: 3.4819958270701994
Receivables turnover: 5.577683068578071
Capitalized R&D asset: 1596035050
ROCI (R&D-adjusted, %): 2.0882452172771138
Rosenberg metric: 0.7353046097744659
FCF margin (%): -9.83076007552404
Revenue growth (%): 76.23484458530699
Rule of 40 score: 66.40408450978295
Financial ratios for DUL.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 13982000
Buffett classification: The Gruesome
Stock price: 252.44444444444443
Shares outstanding: 133512573
Market cap (USD): 33704507317.333332
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DUL.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 236.66666666666666
Shares outstanding: 133512573
Market cap (USD): 31597975610
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DUL.DE — annual report dated 2024-12-31
Total revenue: 2248243000
Gross profit: 1924873000
Operating income: -176885000
Net income: -278157000
Capital expenditures: 34277000
Operating cash flow: -8312000
Depreciation & amortization: 56670000
Net tangible assets: 67088000
Owner earnings: -255764000
Return on net tangible assets (%): -381.23658478416405
Buffett classification: The Gruesome
Stock price: 236.66666666666666
Shares outstanding: 133512573
Book value: 67088000
P/B ratio: 470.99295865132365
Market cap (USD): 31597975610
Debt to equity: 19.318626281898403
Current ratio: 2.777849430821936
Quick ratio: 2.7116681503061693
Interest coverage ratio: -1.2469159300145216
COGS to revenue (%): 14.383231705825395
R&D to revenue (%): 50.09387330462054
SG&A to revenue (%): 43.39059434411672
Free cash flow (dilution-adjusted): -314673000
Buyback yield (%): 0
Retained earnings: -7287748000
Inventory turnover: 4.118890827803182
Receivables turnover: 5.5469988255844935
Capitalized R&D asset: 2090585000
ROCI (R&D-adjusted, %): -1.0731691955517333
Rosenberg metric: 0.405198050606572
FCF margin (%): -13.996396297019494
Revenue growth (%): 22.969580351497463
Rule of 40 score: 8.973184054477969
Financial ratios for DUL.DE — quarterly report dated 2025-03-31
Total revenue: 594189000
Gross profit: 523148000
Operating income: 18077000
Net income: -18251000
Capital expenditures: 8970000
Operating cash flow: -120312000
Depreciation & amortization: 14405000
Net tangible assets: 115435000
Owner earnings: -12816000
Return on net tangible assets (%): -11.102351972971803
Capex to operating income (%): 49.62106544227471
Buffett classification: The Good
Stock price: 246.9565217391304
Shares outstanding: 133512573
Book value: 115435000
P/B ratio: 285.63088003224095
Market cap (USD): 32971800636.521736
Debt to equity: 11.27593884003985
Current ratio: 3.038479095370776
Quick ratio: 2.9775088483604386
Interest coverage ratio: 0.31002075151348846
COGS to revenue (%): 11.955960140628655
R&D to revenue (%): 44.619136335408434
SG&A to revenue (%): 40.382605534602625
Free cash flow (dilution-adjusted): -185994000
Buyback yield (%): 0
Retained earnings: -7345227000
Inventory turnover: 1.0832558210457297
Receivables turnover: 1.4213857691341634
Capitalized R&D asset: 265122000
ROCI (R&D-adjusted, %): 5.724574017647526
FCF margin (%): -31.302161433483285
Rule of 40 score: -31.302161433483285
Financial ratios for DUL.DE — quarterly report dated 2025-06-30
Total revenue: 773689000
Gross profit: 630736000
Operating income: -16199000
Net income: -66277000
Capital expenditures: 14293000
Operating cash flow: 155728000
Depreciation & amortization: 13944000
Net tangible assets: 250591000
Owner earnings: -66626000
Return on net tangible assets (%): -26.587547038800274
Buffett classification: The Gruesome
Stock price: 267.29411764705884
Shares outstanding: 133512573
Book value: 250591000
P/B ratio: 142.4118399895588
Market cap (USD): 35687125394.82353
Debt to equity: 5.176019888982445
Current ratio: 2.801020412085357
Quick ratio: 2.7459117021448334
Interest coverage ratio: -0.4024996272921533
COGS to revenue (%): 18.476803987131778
R&D to revenue (%): 41.82830568871989
SG&A to revenue (%): 41.7886256622493
Free cash flow (dilution-adjusted): 29755000
Buyback yield (%): 0
Retained earnings: -7411504000
Inventory turnover: 1.9940994308670907
Receivables turnover: 1.3642613804680557
Capitalized R&D asset: 501252740
ROCI (R&D-adjusted, %): 2.951720557499666
Rosenberg metric: 0.4058056291066
FCF margin (%): 3.845860546033354
Revenue growth (%): 30.209243186932106
Rule of 40 score: 34.05510373296546
Financial ratios for DUL.DE — quarterly report dated 2025-09-30
Total revenue: 1249026000
Gross profit: 1048872000
Operating income: 367982000
Net income: 251084000
Capital expenditures: 12142000
Operating cash flow: 325109000
Depreciation & amortization: 13803000
Net tangible assets: 233894000
Owner earnings: 252745000
Return on net tangible assets (%): 108.05963385123177
Capex to operating income (%): 3.2996179160937222
Buffett classification: The Great
Stock price: 267.29411764705884
P/E ratio: 214.26502434510635
Shares outstanding: 133512573
Book value: 233894000
P/B ratio: 152.57819950414947
Market cap (USD): 35687125394.82353
Debt to equity: 5.5942093426936985
Current ratio: 2.5412211173807133
Quick ratio: 2.4927581700018706
Effective tax rate (%): -5.069695232436007
Interest coverage ratio: 8.288256227758007
COGS to revenue (%): 16.02480652924759
R&D to revenue (%): 28.727504471484185
SG&A to revenue (%): 25.786172585678763
Free cash flow (dilution-adjusted): 204756000
Buyback yield (%): 0
Retained earnings: -7160420000
Inventory turnover: 2.6551609779393233
Receivables turnover: 1.2946387110683604
Capitalized R&D asset: 663130330
ROCI (R&D-adjusted, %): 10.379159839907642
Rosenberg metric: 1.2920545947265474
FCF margin (%): 16.393253623223217
Revenue growth (%): 61.43773531742083
Rule of 40 score: 77.83098894064405
Financial ratios for DUL.DE — quarterly report dated 2025-12-31
Total revenue: 1097033000
Gross profit: 829310000
Operating income: 131718000
Net income: 186419000
Capital expenditures: 23292000
Operating cash flow: 163555000
Depreciation & amortization: 13506000
Net tangible assets: 789176000
Owner earnings: 176633000
Return on net tangible assets (%): 22.381952821677295
Capex to operating income (%): 17.68323236004191
Buffett classification: The Great
Stock price: 394.5882352941176
P/E ratio: 149.25275322514923
Shares outstanding: 133512573
Book value: 789176000
P/B ratio: 66.75632630699243
Market cap (USD): 52682490569.64706
Debt to equity: 1.619903544963354
Current ratio: 2.76241331361088
Quick ratio: 2.7060017772031077
Effective tax rate (%): -15.689754680799567
Interest coverage ratio: 1.0184092719020852
COGS to revenue (%): 24.404279543094876
R&D to revenue (%): 33.92951716128867
SG&A to revenue (%): 29.65945418232633
Free cash flow (dilution-adjusted): 68631000
Buyback yield (%): 0
Retained earnings: -6702524000
Inventory turnover: 3.2365357414862364
Receivables turnover: 1.4108533412554802
Capitalized R&D asset: 719418310
ROCI (R&D-adjusted, %): 3.611532180031527
Rosenberg metric: -0.6119103490945169
FCF margin (%): 6.256056107701409
Revenue growth (%): -12.168922024041134
Rule of 40 score: -5.912865916339725
Financial ratios for DUL.DE — annual report dated 2025-12-31
Total revenue: 3713937000
Gross profit: 3032066000
Operating income: 501578000
Net income: 313747000
Capital expenditures: 58697000
Operating cash flow: 524080000
Depreciation & amortization: 55658000
Net tangible assets: 789176000
Owner earnings: 310708000
Return on net tangible assets (%): 39.371192230883864
Capex to operating income (%): 11.702467014103489
Buffett classification: The Great
Stock price: 394.5882352941176
P/E ratio: 167.9139260921923
Shares outstanding: 133512573
Book value: 789176000
P/B ratio: 66.75632630699243
Market cap (USD): 52682490569.64706
Debt to equity: 1.619903544963354
Current ratio: 2.76241331361088
Quick ratio: 2.7060017772031077
Effective tax rate (%): 2.9103951081843835
Interest coverage ratio: 1.9854489029280322
COGS to revenue (%): 18.3597890863523
R&D to revenue (%): 35.53574010544605
SG&A to revenue (%): 32.59917979222588
Free cash flow (dilution-adjusted): 117148000
Buyback yield (%): 0
Retained earnings: -6702524000
Inventory turnover: 8.243221025399244
Receivables turnover: 4.776356249686522
Capitalized R&D asset: 2405807390
ROCI (R&D-adjusted, %): 11.365327969024193
Rosenberg metric: 0.9830949573444903
FCF margin (%): 3.1542807538200024
Revenue growth (%): 65.19286393864009
Rule of 40 score: 68.34714469246009
Financial ratios for EMA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40.21
Shares outstanding: 305900000
Market cap (USD): 12300239000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMA — annual report dated 2022-12-31
Total revenue: 5579411764.705882
Gross profit: 2221323529.4117646
Operating income: 1251470588.235294
Net income: 741911764.7058823
Capital expenditures: 1908823529.4117646
Operating cash flow: 671323529.4117646
Depreciation & amortization: 705147058.8235294
Net tangible assets: 3981617647.058823
Owner earnings: -461764705.8823528
Return on net tangible assets (%): -11.597414589104337
Capex to operating income (%): 152.5264394829612
Buffett classification: The Gruesome
Stock price: 32.44
P/E ratio: 13.375439603567887
Shares outstanding: 305900000
Book value: 8412500000
P/B ratio: 1.1796013075780087
Market cap (USD): 9923396000
Debt to equity: 1.664539812953413
Current ratio: 0.6718814326883491
Quick ratio: 0.56635103609167
Effective tax rate (%): 15.494137353433835
Interest coverage ratio: 2.4005641748942175
COGS to revenue (%): 60.18713758566157
SG&A to revenue (%): -0.316288877174486
Free cash flow (dilution-adjusted): -1237500000
Buyback yield (%): 0
Retained earnings: 1164705882.352941
Inventory turnover: 5.93888166449935
Receivables turnover: 4.532855436081243
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.244184255122477
FCF margin (%): -22.179757511860835
Rule of 40 score: -22.179757511860835
Financial ratios for EMA — annual report dated 2023-12-31
Total revenue: 5729545454.545454
Gross profit: 2481818181.8181815
Operating income: 1359090909.090909
Net income: 791666666.6666666
Capital expenditures: 2225000000
Operating cash flow: 1697727272.7272727
Depreciation & amortization: 803030303.030303
Net tangible assets: 4699242424.242424
Owner earnings: -630303030.3030305
Return on net tangible assets (%): -13.41286474286636
Capex to operating income (%): 163.7123745819398
Buffett classification: The Gruesome
Stock price: 33.56
P/E ratio: 12.967584
Shares outstanding: 305900000
Book value: 9157575757.575756
P/B ratio: 1.1210394837855726
Market cap (USD): 10266004000
Debt to equity: 1.6378226340172073
Current ratio: 0.8160211267605634
Quick ratio: 0.6421654929577464
Effective tax rate (%): 10.912190963341859
Interest coverage ratio: 1.9125799573560767
COGS to revenue (%): 56.68385561285204
SG&A to revenue (%): -0.4627793203755124
Free cash flow (dilution-adjusted): -527272727.27272725
Buyback yield (%): 0
Retained earnings: 1365909090.9090908
Inventory turnover: 5.426582278481012
Receivables turnover: 6.503009458297506
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.135104190519808
FCF margin (%): -9.202697342324475
Revenue growth (%): 2.6908515838405096
Rule of 40 score: -6.5118457584839655
Financial ratios for EMA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.48
Shares outstanding: 305900000
Market cap (USD): 11159231999.999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 35.69
Shares outstanding: 305900000
Market cap (USD): 10917571000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMA — annual report dated 2024-12-31
Total revenue: 5034965034.965035
Gross profit: 2023776223.776224
Operating income: 912587412.5874126
Net income: 397202797.20279723
Capital expenditures: 2203496503.496504
Operating cash flow: 1850349650.3496504
Depreciation & amortization: 814685314.6853148
Net tangible assets: 5188111888.111888
Owner earnings: -991608391.6083918
Return on net tangible assets (%): -19.113088017253002
Capex to operating income (%): 241.45593869731803
Buffett classification: The Gruesome
Stock price: 35.69
P/E ratio: 27.48613825704225
Shares outstanding: 305900000
Book value: 9294405594.405594
P/B ratio: 1.174638968474908
Market cap (USD): 10917571000
Debt to equity: 1.4902565645925816
Current ratio: 0.7210166177908113
Quick ratio: 0.5683284457478005
Effective tax rate (%): -38.87530562347188
Interest coverage ratio: 1.3302752293577982
COGS to revenue (%): 59.80555555555556
Free cash flow (dilution-adjusted): -353146853.14685315
Buyback yield (%): 0
Retained earnings: 1026573426.5734266
Inventory turnover: 5.513444302176697
Receivables turnover: 6.070826306913997
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4490960989533774
FCF margin (%): -7.013888888888889
Revenue growth (%): -12.12278399902357
Rule of 40 score: -19.13667288791246
Financial ratios for EMA — quarterly report dated 2025-03-31
Total revenue: 1871328671.3286715
Gross profit: 953146853.1468532
Operating income: 646853146.8531469
Net income: 420279720.2797203
Capital expenditures: 506293706.2937063
Operating cash flow: 488811188.8111888
Depreciation & amortization: 224475524.4755245
Net tangible assets: 5507692307.692307
Owner earnings: 138461538.46153843
Return on net tangible assets (%): 2.5139664804469266
Capex to operating income (%): 78.27027027027026
Buffett classification: The Gruesome
Stock price: 40.72
P/E ratio: 7.4094986023294505
Shares outstanding: 305900000
Book value: 9610489510.48951
P/B ratio: 1.2961096296296297
Market cap (USD): 12456248000
Debt to equity: 1.46132576584443
Current ratio: 0.9231303542486687
Quick ratio: 0.748089835610095
Effective tax rate (%): 16.52777777777778
Interest coverage ratio: 3.627450980392157
COGS to revenue (%): 49.06576980568012
Free cash flow (dilution-adjusted): -17482517.482517485
Buyback yield (%): 0
Retained earnings: 1283916083.916084
Inventory turnover: 1.7367724867724867
Receivables turnover: 2.0841121495327104
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3538093541656067
FCF margin (%): -0.9342301943198804
Rule of 40 score: -0.9342301943198804
Financial ratios for EMA — quarterly report dated 2025-06-30
Total revenue: 1451094890.510949
Gross profit: 589051094.8905109
Operating income: 270072992.7007299
Net income: 112408759.12408759
Capital expenditures: 727007299.2700729
Operating cash flow: 72992700.729927
Depreciation & amortization: 232116788.32116786
Net tangible assets: 5544525547.445255
Owner earnings: -382481751.8248175
Return on net tangible assets (%): -6.89836756187467
Capex to operating income (%): 269.18918918918916
Buffett classification: The Gruesome
Stock price: 44.85
P/E ratio: 25.75541903094127
Shares outstanding: 305900000
Book value: 9608759124.08759
P/B ratio: 1.4278238035551507
Market cap (USD): 13719615000
Debt to equity: 1.531297477970222
Current ratio: 0.6765957446808512
Quick ratio: 0.5388936170212767
Effective tax rate (%): -6.206896551724139
Interest coverage ratio: 1.4859437751004017
COGS to revenue (%): 59.406438631790735
Free cash flow (dilution-adjusted): -654014598.540146
Buyback yield (%): 0
Retained earnings: 1281021897.8102188
Inventory turnover: 1.4598269468479605
Receivables turnover: 1.3748271092669433
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.009384548232213
FCF margin (%): -45.07042253521127
Revenue growth (%): -22.456438959990404
Rule of 40 score: -67.52686149520167
Financial ratios for EMA — quarterly report dated 2025-09-30
Total revenue: 1515107913.6690648
Gross profit: 667625899.2805756
Operating income: 345323741.0071943
Net income: 178417266.18705037
Capital expenditures: 608633093.5251799
Operating cash flow: 569064748.2014389
Depreciation & amortization: 233093525.17985612
Net tangible assets: 5613669064.748201
Owner earnings: -197122302.15827334
Return on net tangible assets (%): -3.5114699474561055
Capex to operating income (%): 176.24999999999997
Buffett classification: The Gruesome
Stock price: 47.48
P/E ratio: 20.424714734841423
Shares outstanding: 305900000
Book value: 9700719424.460434
P/B ratio: 1.4972221506971222
Market cap (USD): 14524131999.999998
Debt to equity: 1.5309997033521208
Current ratio: 0.641491395793499
Quick ratio: 0.5060548119821542
Effective tax rate (%): 2.3622047244094486
Interest coverage ratio: 1.8461538461538463
COGS to revenue (%): 55.93542260208927
Free cash flow (dilution-adjusted): -39568345.32374101
Buyback yield (%): 0
Retained earnings: 1270503597.1223023
Inventory turnover: 1.3858823529411763
Receivables turnover: 1.5383491599707815
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2790790630745863
FCF margin (%): -2.6115859449192786
Revenue growth (%): 4.411360247817844
Rule of 40 score: 1.799774302898565
Financial ratios for EMA — quarterly report dated 2025-12-31
Total revenue: 1464233576.6423357
Gross profit: 534306569.3430657
Operating income: 200729927.00729924
Net income: 63503649.63503649
Capital expenditures: 705109489.0510949
Operating cash flow: 154744525.54744524
Depreciation & amortization: 244525547.44525546
Net tangible assets: 5694890510.948905
Owner earnings: -397080291.97080296
Return on net tangible assets (%): -6.972571135606255
Capex to operating income (%): 351.2727272727273
Buffett classification: The Gruesome
Stock price: 48.74
P/E ratio: 19.247850712747958
Shares outstanding: 305900000
Book value: 9778102189.781021
P/B ratio: 1.5247913869811887
Market cap (USD): 14909566000
Debt to equity: 1.6020453866825919
Current ratio: 0.6622906292440018
Quick ratio: 0.5384035008299383
Effective tax rate (%): -67.3076923076923
Interest coverage ratio: 1.0826771653543308
COGS to revenue (%): 63.50947158524427
Free cash flow (dilution-adjusted): -550364963.5036496
Buyback yield (%): 0
Retained earnings: 1178102189.7810218
Inventory turnover: 1.5517661388550548
Receivables turnover: 1.1443240159726182
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7200837915684732
FCF margin (%): -37.587238285144565
Revenue growth (%): -3.3578028711848744
Rule of 40 score: -40.94504115632944
Financial ratios for EMA — annual report dated 2025-12-31
Total revenue: 6405839416.0583935
Gross profit: 2795620437.956204
Operating income: 1496350364.9635036
Net income: 795620437.9562043
Capital expenditures: 2578102189.7810216
Operating cash flow: 1315328467.1532845
Depreciation & amortization: 947445255.4744525
Net tangible assets: 5694890510.948905
Owner earnings: -835036496.3503647
Return on net tangible assets (%): -14.66290694693668
Capex to operating income (%): 172.29268292682923
Buffett classification: The Gruesome
Stock price: 48.74
P/E ratio: 18.739546256880736
Shares outstanding: 305900000
Book value: 9778102189.781021
P/B ratio: 1.5247913869811887
Market cap (USD): 14909566000
Debt to equity: 1.6020453866825919
Current ratio: 0.6622906292440018
Quick ratio: 0.5384035008299383
Effective tax rate (%): 6.917164816396242
Interest coverage ratio: 2.013752455795678
COGS to revenue (%): 56.35824977210575
Free cash flow (dilution-adjusted): -1262773722.627737
Buyback yield (%): 0
Retained earnings: 1178102189.7810218
Inventory turnover: 6.02436053593179
Receivables turnover: 5.0062749572162
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.36789735532862
FCF margin (%): -19.71285323609845
Revenue growth (%): 27.22708840227086
Rule of 40 score: 7.5142351661724085
Financial ratios for EMB.AX — annual report dated 2021-06-30
Total revenue: 51215673.684210524
Gross profit: 11632193.984962406
Operating income: 926437.5939849623
Net income: 1081954.887218045
Capital expenditures: 345864.6616541353
Depreciation & amortization: 739190.2255639097
Net tangible assets: 13901387.969924811
Owner earnings: 1475280.4511278197
Return on net tangible assets (%): 10.612468728443087
Capex to operating income (%): 37.33275332302084
Buffett classification: The Good
Stock price: 7.616541353383459
P/E ratio: 15.190473530229328
Shares outstanding: 2157857
Book value: 22899009.022556387
P/B ratio: 0.7177344250573671
Market cap (USD): 16435407.075187972
Debt to equity: 0.08037908985259304
Current ratio: 1.76651564119899
Quick ratio: 0.508272553846353
Effective tax rate (%): 31.833254381809567
Interest coverage ratio: 6.845344444444444
COGS to revenue (%): 77.2878239253767
SG&A to revenue (%): 19.155875185413016
Free cash flow (dilution-adjusted): 4485714.285714285
Buyback yield (%): 0
Retained earnings: 13526315.789473683
Inventory turnover: 2.114759398746016
Receivables turnover: 7.692472727272727
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.759952264649238
FCF margin (%): 8.758479510340218
Rule of 40 score: 8.758479510340218
Financial ratios for EMB.AX — annual report dated 2022-06-30
Total revenue: 45457396.551724136
Gross profit: 9720343.448275862
Operating income: 381415.1724137931
Net income: 668275.8620689656
Capital expenditures: 210344.8275862069
Depreciation & amortization: 700008.275862069
Net tangible assets: 12910928.27586207
Owner earnings: 1157939.3103448276
Return on net tangible assets (%): 8.96867588142117
Capex to operating income (%): 55.14852129636997
Buffett classification: The Good
Stock price: 5.944827586206896
P/E ratio: 19.19579704850361
Shares outstanding: 2157857
Book value: 23933071.724137936
P/B ratio: 0.5359983861892562
Market cap (USD): 12828087.820689656
Debt to equity: 0.42767491781823525
Current ratio: 2.5579465972789537
Quick ratio: 0.580908794365821
Effective tax rate (%): 33.53909465020576
Interest coverage ratio: 2.5253515981735157
COGS to revenue (%): 78.61658567002299
SG&A to revenue (%): 18.75999391624367
Free cash flow (dilution-adjusted): -4410344.827586207
Buyback yield (%): 0
Retained earnings: 12554482.75862069
Inventory turnover: 1.3920111425949515
Receivables turnover: 7.521764806573091
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1920520494534812
FCF margin (%): -9.702150061690958
Revenue growth (%): -11.24319318338212
Rule of 40 score: -20.945343245073076
Financial ratios for EMB.AX — annual report dated 2023-06-30
Total revenue: 49210684.76821192
Gross profit: 9887478.145695364
Operating income: 214599.33774834438
Net income: 629139.0728476822
Capital expenditures: 13245.033112582782
Depreciation & amortization: 681998.0132450331
Net tangible assets: 12601954.304635761
Owner earnings: 1297892.0529801324
Return on net tangible assets (%): 10.299133147171382
Capex to operating income (%): 6.171982286410838
Buffett classification: The Great
Stock price: 6.172185430463577
P/E ratio: 21.169712884210526
Shares outstanding: 2157857
Book value: 24870393.377483442
P/B ratio: 0.535524039940679
Market cap (USD): 13318693.536423841
Debt to equity: 0.16112671429797082
Current ratio: 1.8908747031406326
Quick ratio: 0.5004217485937698
Effective tax rate (%): 24.30278884462151
Interest coverage ratio: 0.4977649769585254
COGS to revenue (%): 79.90786311495859
SG&A to revenue (%): 18.093923607340212
Free cash flow (dilution-adjusted): 2324503.3112582783
Buyback yield (%): 0
Retained earnings: 12256291.390728477
Inventory turnover: 1.8377953181904902
Receivables turnover: 7.5747333333333335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8522948297033159
FCF margin (%): 4.723574407076351
Revenue growth (%): 8.256716180868546
Rule of 40 score: 12.980290587944896
Financial ratios for EMB.AX — annual report dated 2024-06-30
Total revenue: 46549072.666666664
Gross profit: 10224692
Operating income: 727333.3333333334
Net income: 840666.6666666666
Capital expenditures: 560666.6666666666
Depreciation & amortization: 671843.3333333334
Net tangible assets: 13000898
Owner earnings: 951843.3333333334
Return on net tangible assets (%): 7.321366057431828
Capex to operating income (%): 77.08524289642529
Buffett classification: The Gruesome
Stock price: 5.8066666666666675
P/E ratio: 14.904785463917529
Shares outstanding: 2157857
Book value: 22808154
P/B ratio: 0.5493630178634069
Market cap (USD): 12529956.313333334
Debt to equity: 0.012860897612903408
Current ratio: 2.4593639787105337
Quick ratio: 0.8412069192448438
Effective tax rate (%): 30.33149171270718
Interest coverage ratio: 3.090651558073654
COGS to revenue (%): 78.03459571962257
SG&A to revenue (%): 18.724219769276036
Free cash flow (dilution-adjusted): 5199333.333333333
Buyback yield (%): 0
Retained earnings: 12675333.333333334
Inventory turnover: 2.83370252488955
Receivables turnover: 10.05524323156682
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1535227059849382
FCF margin (%): 11.169574462987155
Revenue growth (%): -5.408606106746459
Rule of 40 score: 5.760968356240697
Financial ratios for EPIGRAL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.62969800870368
Shares outstanding: 43141338
Market cap (USD): 544862070.6314124
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPIGRAL.NS — annual report dated 2023-03-31
Total revenue: 264243800.24360538
Gross profit: 122035054.81120585
Operating income: 70645432.3995128
Net income: 43031741.77831913
Capital expenditures: 50725261.87576127
Operating cash flow: 76268172.95980512
Depreciation & amortization: 13270803.89768575
Net tangible assets: 127150535.9317905
Owner earnings: 5577283.800243609
Return on net tangible assets (%): 4.386362793811207
Capex to operating income (%): 71.8026065562182
Buffett classification: The Good
Stock price: 11.342752740560293
P/E ratio: 11.37164124919259
Shares outstanding: 43141338
Book value: 130219269.18392208
P/B ratio: 3.7578273392073065
Market cap (USD): 489341529.8309379
Debt to equity: 0.7190740400198221
Current ratio: 0.6476848124219825
Quick ratio: 0.32063323454643855
Effective tax rate (%): 32.37925509547258
Interest coverage ratio: 11.648811819145859
COGS to revenue (%): 53.81724956320557
SG&A to revenue (%): 1.6425286580657437
Free cash flow (dilution-adjusted): 25542911.08404385
Buyback yield (%): 1.5163656898524474
Retained earnings: 155204628.50182706
Inventory turnover: 5.511701463733346
Receivables turnover: 13.04360028691282
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 32.501229445178396
FCF margin (%): 9.666418307826309
Rule of 40 score: 9.666418307826309
Financial ratios for EPIGRAL.NS — annual report dated 2024-03-31
Total revenue: 227105168.4854299
Gross profit: 93372106.96726227
Operating income: 42893632.33001559
Net income: 23488427.869049046
Capital expenditures: 47780309.38961506
Operating cash flow: 47684374.625254825
Depreciation & amortization: 14817124.355438301
Net tangible assets: 147756325.698525
Owner earnings: -9474757.16512771
Return on net tangible assets (%): -6.412420666482702
Capex to operating income (%): 111.39254661858031
Buffett classification: The Gruesome
Stock price: 13.026151631477926
P/E ratio: 23.92521174707264
Shares outstanding: 43141338
Book value: 150389734.98021346
P/B ratio: 3.7367285104051655
Market cap (USD): 561965610.3728406
Debt to equity: 0.7248544773144087
Current ratio: 0.6438466866774417
Quick ratio: 0.3064983709176736
Effective tax rate (%): 32.63284608770422
Interest coverage ratio: 5.738649125621691
COGS to revenue (%): 58.88596125312198
R&D to revenue (%): 0.04963486690991271
SG&A to revenue (%): 1.7245476098699462
Free cash flow (dilution-adjusted): -95934.76436023504
Buyback yield (%): 1.1736510078241817
Retained earnings: 174988607.74673223
Inventory turnover: 4.240465416936005
Receivables turnover: 10.594853146853147
Capitalized R&D asset: 112723.34812327617
ROCI (R&D-adjusted, %): 17.776289461063982
FCF margin (%): -0.04224243992332997
Revenue growth (%): -14.054684243845076
Rule of 40 score: -14.096926683768405
Financial ratios for EPIGRAL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 164825609.17343527
Buffett classification: The Gruesome
Stock price: 27.100215002388914
Shares outstanding: 43141338
Book value: 167255136.16817963
P/B ratio: 6.990156249163727
Market cap (USD): 1169139535.290731
Debt to equity: 0.6401382600374217
Current ratio: 0.7942883431240712
Quick ratio: 0.3971736617359096
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPIGRAL.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.93437463573843
Shares outstanding: 43141338
Market cap (USD): 946278269.9790184
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EPIGRAL.NS — annual report dated 2025-03-31
Total revenue: 293944353.5188216
Gross profit: 129191021.74421322
Operating income: 67595277.06336217
Net income: 41815524.90063128
Capital expenditures: 21785129.763853166
Operating cash flow: 51503390.22679448
Depreciation & amortization: 15496843.581949964
Net tangible assets: 220458265.1391162
Owner earnings: 35527238.71872808
Return on net tangible assets (%): 16.115176582882597
Capex to operating income (%): 32.2287750125387
Buffett classification: The Good
Stock price: 22.079939316139573
P/E ratio: 22.780011187727208
Shares outstanding: 43141338
Book value: 222647884.03086275
P/B ratio: 4.278316540951386
Market cap (USD): 952558125.0570662
Debt to equity: 0.3111161283886313
Current ratio: 1.5642769224560624
Quick ratio: 0.7813918763494017
Effective tax rate (%): 33.894546193794014
Interest coverage ratio: 13.59854186265287
COGS to revenue (%): 56.049156856506514
R&D to revenue (%): 0.021874005727012407
SG&A to revenue (%): 1.9941139039134586
Free cash flow (dilution-adjusted): 28743277.998597145
Buyback yield (%): 1.1659042182406634
Retained earnings: 208667290.15665185
Inventory turnover: 3.632310111085337
Receivables turnover: 10.823002754820937
Capitalized R&D asset: 139822.04796553167
ROCI (R&D-adjusted, %): 21.75489990029278
Rosenberg metric: 317.75950034573833
FCF margin (%): 9.778475978364618
Revenue growth (%): 29.430939629927355
Rule of 40 score: 39.20941560829198
Financial ratios for EPIGRAL.NS — quarterly report dated 2025-03-31
Total revenue: 73372691.13864858
Gross profit: 34920505.026888005
Operating income: 16299976.619125554
Net income: 10157820.902501753
Capital expenditures: 0
Depreciation & amortization: 3968903.4369885433
Net tangible assets: 220458265.1391162
Owner earnings: 14126724.339490296
Return on net tangible assets (%): 6.407890550429526
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 22.079939316139573
P/E ratio: 23.4439584582177
Shares outstanding: 43141338
Book value: 222647884.03086275
P/B ratio: 4.278316540951386
Market cap (USD): 952558125.0570662
Debt to equity: 0.3111161283886313
Current ratio: 1.5642769224560624
Quick ratio: 0.7813918763494017
Effective tax rate (%): 33.8384222949821
Interest coverage ratio: 11.846219201359387
COGS to revenue (%): 52.40667272118924
Buyback yield (%): 0
Retained earnings: 208667290.15665185
Inventory turnover: 0.8477538080878374
Receivables turnover: 2.7015754132231407
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.247943993827277
Rule of 40 score: 0
Financial ratios for EPIGRAL.NS — quarterly report dated 2025-06-30
Total revenue: 70973554.87947579
Gross profit: 33637959.27919495
Operating income: 14258132.459630238
Net income: 18802948.74795226
Capital expenditures: 0
Depreciation & amortization: 4860753.568921133
Owner earnings: 23663702.316873394
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 21.06728293938685
P/E ratio: 31.382825283977677
Shares outstanding: 43141338
Market cap (USD): 908870774.0297216
Effective tax rate (%): -50.16353611811981
Interest coverage ratio: 5.213949507916132
COGS to revenue (%): 52.60493949286115
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.269794554269889
Rule of 40 score: -3.269794554269889
Financial ratios for EPIGRAL.NS — quarterly report dated 2025-09-30
Total revenue: 66218714.76888388
Gross profit: 29296505.073280722
Operating income: 10152198.421645997
Net income: 5774520.8568207435
Capital expenditures: 0
Depreciation & amortization: 4770011.273957158
Net tangible assets: 234948139.79706877
Owner earnings: 10544532.130777903
Return on net tangible assets (%): 4.488025374401988
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 18.983314543404735
P/E ratio: 23.577335243700347
Shares outstanding: 43141338
Book value: 236877113.86696726
P/B ratio: 3.457343665278188
Market cap (USD): 818965589.0773393
Debt to equity: 0.2556518014373424
Current ratio: 1.3147203081872156
Quick ratio: 0.6312674993546336
Effective tax rate (%): 26.46087580760948
Interest coverage ratio: 4.123168498168497
COGS to revenue (%): 55.75796785616998
Buyback yield (%): 0
Inventory turnover: 0.9515369864605728
Receivables turnover: 2.5912560109410157
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.295094864335767
Revenue growth (%): -6.699453224044327
Rule of 40 score: -6.699453224044327